ACCUM Trademark

Trademark Overview

On Thursday, January 7, 2021, a trademark application was filed for ACCUM with the United States Patent and Trademark Office. The USPTO has given the ACCUM trademark a serial number of 90453057. The federal status of this trademark filing is REGISTERED as of Tuesday, October 3, 2023. This trademark is owned by Defence Therapeutics Inc.. The ACCUM trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines
accum

General Information

Serial Number90453057
Word MarkACCUM
Filing DateThursday, January 7, 2021
Status700 - REGISTERED
Status DateTuesday, October 3, 2023
Registration Number7178708
Registration DateTuesday, October 3, 2023
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, July 18, 2023

Trademark Statements

Goods and ServicesResearch and development of vaccines and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, April 7, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDefence Therapeutics Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6C3L6
CA
Party NameDefence Therapeutics Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressVancouver, BC V6C3L6
CA
Party NameDefence Therapeutics Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressVancouver, BC V6C3L6
CA

Trademark Events

Event DateEvent Description
Tuesday, October 3, 2023NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, October 3, 2023REGISTERED-PRINCIPAL REGISTER
Tuesday, July 18, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 18, 2023PUBLISHED FOR OPPOSITION
Wednesday, June 28, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, June 12, 2023LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, June 5, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Monday, June 5, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, June 5, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, June 1, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Monday, January 30, 2023NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Monday, January 30, 2023LETTER OF SUSPENSION E-MAILED
Monday, January 30, 2023SUSPENSION LETTER WRITTEN
Monday, January 30, 2023TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, January 30, 2023CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, January 28, 2023ASSIGNED TO LIE
Friday, January 20, 2023TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Thursday, August 18, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Thursday, August 18, 2022INQUIRY TO SUSPENSION E-MAILED
Thursday, August 18, 2022SUSPENSION INQUIRY WRITTEN
Thursday, February 17, 2022NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Thursday, February 17, 2022LETTER OF SUSPENSION E-MAILED
Thursday, February 17, 2022SUSPENSION LETTER WRITTEN
Thursday, February 17, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 17, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, February 16, 2022ASSIGNED TO LIE
Friday, February 11, 2022TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Tuesday, January 18, 2022NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Tuesday, January 18, 2022INQUIRY TO SUSPENSION E-MAILED
Tuesday, January 18, 2022SUSPENSION INQUIRY WRITTEN
Friday, July 16, 2021NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Friday, July 16, 2021LETTER OF SUSPENSION E-MAILED
Friday, July 16, 2021SUSPENSION LETTER WRITTEN
Thursday, July 15, 2021ASSIGNED TO EXAMINER
Wednesday, April 7, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, January 11, 2021NEW APPLICATION ENTERED

Related Keywords

accum medicines vaccines development research